OTCMKTS:RYMDF

Relay Medical Stock Forecast, Price & News

$0.25
+0.02 (+7.81 %)
(As of 05/7/2021 03:27 PM ET)
Add
Compare
Today's Range
$0.24
$0.26
50-Day Range
$0.24
$0.52
52-Week Range
$0.13
$0.72
Volume59,211 shs
Average Volume144,578 shs
Market Capitalization$37.18 million
P/E RatioN/A
Dividend YieldN/A
Beta1.49
30 days | 90 days | 365 days | Advanced Chart
Receive RYMDF News and Ratings via Email

Sign-up to receive the latest news and ratings for Relay Medical and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:RYMDF
CUSIPN/A
CIKN/A
Phone647 872 9982
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual SalesN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap$37.18 million
Next Earnings Date6/7/2021 (Estimated)
OptionableNot Optionable

Headlines

See More Headlines
Relay Medical logo

About Relay Medical

Relay Medical Corp. develops and sells products in the medical device, consumer health, and health IT industries. The company provides Fionet, a mobile testing and tracking platform, which combines handheld devices linked to online AI-powered cloud, automating frontline testing, and capturing test results for tracking; HemoPalm, a blood analyzer and single-use cartridge that provides enterprise solution for point-of-care blood gas and CO-oximetry testing; and Pharmatrac, an user experience -centric system design to improve management and identification of medications. It offers techno-commercial leadership and support services for the venture that pursue technology opportunities in the medicinal cannabis, agrotechnology, and other related industries. The company was formerly known as ChroMedX Corp. and changed its name to Relay Medical Corp. in June 2018. Relay Medical Corp. is headquartered in Toronto, Canada.

MarketRank

Overall MarketRank

0.00 out of 5 stars

Medical Sector

1869th out of 2,042 stocks

Diagnostics & Research Industry

14th out of 15 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Relay Medical (OTCMKTS:RYMDF) Frequently Asked Questions

What stocks does MarketBeat like better than Relay Medical?

Wall Street analysts have given Relay Medical a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Relay Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Relay Medical?

Relay Medical saw a increase in short interest in March. As of March 31st, there was short interest totaling 200,600 shares, an increase of 34.5% from the March 15th total of 149,100 shares. Based on an average trading volume of 104,900 shares, the short-interest ratio is currently 1.9 days.
View Relay Medical's Short Interest
.

When is Relay Medical's next earnings date?

Relay Medical is scheduled to release its next quarterly earnings announcement on Monday, June 7th 2021.
View our earnings forecast for Relay Medical
.

How were Relay Medical's earnings last quarter?

Relay Medical Corp. (OTCMKTS:RYMDF) posted its quarterly earnings results on Monday, March, 1st. The company reported ($0.02) earnings per share (EPS) for the quarter.
View Relay Medical's earnings history
.

Who are Relay Medical's key executives?

Relay Medical's management team includes the following people:
  • Mr. W. Clark Kent, Pres & Director
  • Mr. Yoav Raiter, Chief Exec. Officer
  • Mr. Christopher J. Hopkins C.A., CPA, M.B.A., CPA, CA, MBA, Chief Financial Officer (Age 57)
  • Ms. Jessica Kuhn, Director of Operations
  • Mr. Igal Roytblat, Chief Technology Officer
  • Mr. Tom Glawdel Ph.D., Chief Scientific Officer
  • Mr. Ian Fine, VP of R&D and CTO of Fionet Rapid Response Group

Who are some of Relay Medical's key competitors?

What is Relay Medical's stock symbol?

Relay Medical trades on the OTCMKTS under the ticker symbol "RYMDF."

How do I buy shares of Relay Medical?

Shares of RYMDF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Relay Medical's stock price today?

One share of RYMDF stock can currently be purchased for approximately $0.25.

How much money does Relay Medical make?

Relay Medical has a market capitalization of $37.18 million.

What is Relay Medical's official website?

The official website for Relay Medical is www.relaymedical.com.

How can I contact Relay Medical?

The company can be reached via phone at 647 872 9982.


This page was last updated on 5/9/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.